Sondelbay® 20 micrograms/80 microliters injectable solution
It is indicated in adults, for:
The recommended dose of Sondelbay® is 20 micrograms administered once daily, with a maximum recommended duration of the treatment of 24 months.
This drug is subject to additional follow-up. Reporting suspected adverse reactions associated with this medicine is important.
Access technical file SONDELBAY® 20 MICROGRAMS/80 MICROLITERS INJECTABLE SOLUTION
Sondelbay® 20 micrograms/80 microliters injectable solution
Sondelbay® is available in a pack of 1 pre-filled pen with 2.4 ml containing 600 micrograms of teriparatide (corresponding to 250 micrograms per ml).
Each pre-filled pen contains 28 doses of 20 micrograms (per 80 microlitres). No need to replace cartridges.
Ownership: Accord Healthcare S.L.U.
Marketed by: Marketed and distributed in Spain by Laboratorios Rubió as a local representative.
Last update: July 2024
This drug is subject to additional follow-up. Reporting suspected adverse reactions associated with this medicine is important.
The information contained in this area is directed exclusively to healthcare professionals with the capacity to prescribe or dispense medications.